Department of Biotechnology, Sri Venkateswara Institute of Medical Sciences, Tirupati, 517507, Andhra Pradesh, India.
Department of Hematology, Sri Venkateswara Institute of Medical Sciences, Tirupati, 517507, Andhra Pradesh, India.
Biochem Biophys Res Commun. 2018 Oct 20;505(1):168-175. doi: 10.1016/j.bbrc.2018.09.090. Epub 2018 Sep 20.
Megakaryocytopoiesis results in the formation of platelets, which are essential for hemostasis. Decreased production or increased destruction of platelets can cause thrombocytopenia, in which platelet transfusion is the mode of treatment. The present study is aimed in generation of megakaryocytes (MKs) and platelet from human hematopoietic stem cells (HSCs). The purity of HSCs was assessed through Flow cytometry and immunocytochemistry (ICC) studies. These pure HSCs were induced with thrombopoietin (TPO), similarly with Andrographis paniculata extract (APE) for 21 days to generate MKs. The APE is mainly composed of andrographolide which stimulates TPO from the liver, and this binds to CD110 present on the surface of HSCs and triggers the proliferation of HSCs and initiate higher MKs population subsequently, a large number of platelets. The results of the present study showed increased proliferation of HSCs grown in the presence of APE and revealed a high population of CD41a and CD42b positive MKs as enumerated by Flow cytometry compared with TPO induced MKs. These results also concurred with qRT-PCR and western blot analysis. The scanning electron microscopy (SEM) revealed the morphology of differentiated MKs and platelets were similar to human blood platelets. The differentiated MKs in APE exhibited polyploidy up to 32 N while TPO induced MKs showed polyploidy of 8 N, these results corroborated with colony forming unit assay. On thrombin stimulation, high expression of P-selectin (CD62p) and fibrinogen binding were detected in APE induced platelets. Autologous transplantation of platelets generated from APE may be a useful option in thrombocytopenia condition.
巨核细胞生成导致血小板形成,血小板对于止血至关重要。血小板生成减少或破坏增加可导致血小板减少症,其治疗方法是血小板输注。本研究旨在从人造血干细胞(HSCs)中生成巨核细胞(MKs)和血小板。通过流式细胞术和免疫细胞化学(ICC)研究评估 HSCs 的纯度。将这些纯 HSCs 用血小板生成素(TPO)和穿心莲提取物(APE)诱导 21 天以生成 MKs。APE 主要由刺激肝脏产生 TPO 的穿心莲内酯组成,该物质与 HSCs 表面的 CD110 结合,触发 HSCs 的增殖,并随后启动更高的 MKs 群体,从而产生大量血小板。本研究结果表明,在 APE 存在下生长的 HSCs 增殖增加,并通过流式细胞术显示出与 TPO 诱导的 MKs 相比,CD41a 和 CD42b 阳性 MKs 的高群体。这些结果也与 qRT-PCR 和 Western blot 分析一致。扫描电子显微镜(SEM)显示分化的 MKs 和血小板的形态与人类血小板相似。APE 中分化的 MKs 表现出多达 32N 的多倍体,而 TPO 诱导的 MKs 则表现出 8N 的多倍体,这些结果与集落形成单位测定相符。在凝血酶刺激下,在 APE 诱导的血小板中检测到 P-选择素(CD62p)和纤维蛋白原结合的高表达。从 APE 生成的血小板进行自体移植可能是血小板减少症的一种有用选择。